FGF23浓度与APOL1基因型是非裔美国人2型糖尿病死亡的新预测因素
在513例非裔美国人2型糖尿病患者中评估死亡预测因素,中位随访6.6年记录54例死亡。校正年龄、性别和非裔祖先比例后,冠脉钙化斑块、颈动脉钙化斑块、白蛋白尿和FGF23较高与死亡较高相关;惩罚Cox回归识别男性、较高FGF23及缺乏APOL1肾脏风险基因型为最强预测因素。
要点
- 较高FGF23浓度与死亡风险独立相关(HR 2.10,95%CI 1.59-2.78)。
- 男性性别与死亡风险升高相关(HR 4.17,95%CI 1.96-9.09)。
- 缺乏APOL1肾脏风险基因型与死亡风险升高相关(HR 0.07,95%CI 0.01-0.69)。
核心结论
- 在非裔美国人2型糖尿病患者中,校正传统危险因素后,较高FGF23浓度和APOL1非肾脏风险基因型与较高死亡风险相关。
研究设计与样本
- 研究纳入513例非裔美国人2型糖尿病患者,采用Cox比例风险模型分析死亡与亚临床动脉粥样硬化、尿白蛋白肌酐比、估算肾小球滤过率、血浆FGF23浓度、非裔祖先比例及APOL1基因型的关联。
主要发现
- 随访6.6年(5.8,7.5)期间记录54例死亡。
- 校正年龄、性别和非裔祖先比例后,较高水平的冠状动脉钙化斑块、颈动脉钙化斑块、白蛋白尿和FGF23与较高死亡率相关。
- 包含所有协变量和与死亡相关预测因素的惩罚Cox回归识别男性(HR 4.17,95%CI 1.96-9.09)、较高FGF23(HR 2.10,95%CI 1.59-2.78)及缺乏APOL1肾脏风险基因型(HR 0.07,95%CI 0.01-0.69)为最强死亡预测因素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 这些新预测因素影响生存的机制仍有待确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cardiovascular and renal complications contribute to higher mortality in patients with diabetes. We assessed novel and conventional predictors of mortality in African American-Diabetes Heart Study (AA-DHS) participants. RESEARCH DESIGN AND METHODS: Associations between mortality and subclinical atherosclerosis, urine albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), plasma fibroblast growth factor 23 (FGF23) concentration, African ancestry proportion, and apolipoprotein L1 genotypes (APOL1) were assessed in 513 African Americans with type 2 diabetes; analyses were performed using Cox proportional hazards models. RESULTS: At baseline, participants were 55.6% female with median (25th, 75th percentile) age 55 years (49.0, 62.0), diabetes duration 8 years (5.0, 13.0), glycosylated hemoglobin 60.7 mmol/mol (48.6, 76.0), eGFR 91.3 mL/min/1.73 m2 (76.4, 111.3), UACR 12.5 mg/mmol (4.2, 51.2), and coronary artery calcium 28.5 mg Ca2+ (1.0, 348.6); 11.5% had two APOL1 renal-risk variants. After 6.6-year follow-up (5.8, 7.5), 54 deaths were recorded. Higher levels of coronary artery calcified plaque, carotid artery calcified plaque, albuminuria, and FGF23 were associated with higher mortality after adjustment for age, sex, and African ancestry proportion. A penalized Cox regression that included all covariates and predictors associated with mortality identified male sex (hazard ratio [HR] 4.17 [95% CI 1.96-9.09]), higher FGF23 (HR 2.10 [95% CI 1.59-2.78]), and absence of APOL1 renal-risk genotypes (HR 0.07 [95% CI 0.01-0.69]) as the strongest predictors of mortality. CONCLUSIONS: Accounting for conventional risk factors, higher FGF23 concentrations and APOL1 non-renal-risk genotypes associated with higher mortality in African Americans with diabetes. These data add to growing evidence supporting FGF23 association with mortality; mechanisms whereby these novel predictors impact survival remain to be determined.
引用
- Chan GC, Divers J, Russell GB, et al. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes. Diabetes Care. 2017. PMID: 29113983. doi:10.2337/dc17-0820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。